RPCEC00000334已完成未知
Safety and effectiveness of BIOMODULIN T in protective therapy in events of local transmission of COVID-19. Interventional Study (COVID-19)
Centro Nacional de Biopreparados (BioCen)0 个研究点开始时间: 2020年9月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled trial. Masking: Open. Control group: Uncontrolled. Assignment: Parallel. Purpose: Prevention
入排标准
- 年龄范围
- 60 years 至 one(—)
- 性别
- All
入选标准
- •1. Age 60 years and over.
- •2. Any sex and skin color.
- •3. Patients who express their consent in writing, to participate in the study and in the event that major cognitive impairment is present, be signed by a family member, tutor or caregiver.
排除标准
- •1. Patients who have received treatment with BIOMODULINA T® in the previous two months.
- •2. Patients with known hypersensitivity to any component of the formulation.
- •3. Patients with acute allergic states or history of severe allergic reactions.
- •4. Patients with uncontrolled intercurrent illnesses including, but not limited to: acute infections with concomitant febrile symptoms, symptomatic congestive heart failure, unstable angina pectoris.
研究者
相似试验
招募中
不适用
BIOMODULINA T in a long-lived population at high risk of COVID-19 infectioCOVID-19 preventionCOVID-19SARS-CoV2Disease PreventionAgingCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000335Centro Nacional de Biopreparados (BioCen)
招募中
不适用
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adultson-small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesRPCEC00000358Center of Molecular Immunology (CIM)
已完成
不适用
The efficacy of recombinant thrombomodulin for post transplant coagulopathy in childrechildren with coagulopathy after hematopoietic stem cell transplantationJPRN-UMIN000005117Yokohama City University Hospital50
招募中
不适用
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory studyCOVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusDisease PreventionAgingRPCEC00000348ational Center for Bioproducts (BioCen).60
尚未招募
不适用
Biomodulina T in pediatric septic shock. Exploratory studySystemic Inflammatory Response SyndromeShock, SepticShockPathologic ProcessesPediatricsSeptic shockSepsisRPCEC00000327Centro Nacional de Biopreparados (BioCen)60
